Unaudited Condensed Consolidated Statements of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenue	$ 177,496	$ 159,504
Cost of goods sold (excluding amortization of purchased technology)	43,294	39,096
Gross profit	134,202	120,408
Operating expenses:
Sales, marketing and administrative	118,104	99,886
Research and development	9,455	9,694
Amortization of intangible assets	3,998	4,376
Litigation Award	30,000	0
Total operating expenses	161,557	113,956
Interest and other expense, net:
Interest income	217	172
Interest expense	(6,865)	(7,032)
Other income, net	375	240
Total interest and other expense, net	(6,273)	(6,620)
Loss before income taxes	(33,628)	(168)
Income tax benefit	(15,095)	(764)
Consolidated net (loss) income	(18,533)	596
Net loss attributable to noncontrolling interests	(257)	(255)
Net (loss) income attributable to NuVasive, Inc.	$ (18,276)	$ 851
Net (loss) income per share attributable to NuVasive, Inc.:
Earnings Per Share, Basic	$ (0.40)	$ 0.02
Earnings Per Share, Diluted	$ (0.40)	$ 0.02
Weighted average shares outstanding:
Basic (in shares)	45,798	44,025
Diluted (in shares)	45,798	45,316